No profile data available.
CapsoVision, Inc. (CV) is a healthcare company in the targeted healthcare equipment industry, based in Saratoga, United States, with about 90 full-time employees.
It reported revenue of $13.55 million for fiscal year 2025, up 15.3% from fiscal year 2024, and net income of -$25.32 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $3.64 million, up 9.9% from a year before. UNITED STATES was its largest region in fiscal year 2025, with 84% of revenue. Its market capitalization was $299.80 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system.
CapsoVision reported $13.55 million in revenue for fiscal year 2025, up 15.3% from $11.76 million in fiscal year 2024. In Q2 2026 revenue was $3.64 million.
UNITED STATES: 84% of revenue by region in fiscal year 2025, followed by FRANCE (11%).
$299.80 million as of December 4, 2025.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include BrainsWay Ltd. (BWAY), NeuroPace, Inc. (NPCE), ClearPoint Neuro, Inc. (CLPT), Humacyte, Inc. (HUMA).